BPC-157 – Research Peptide
US$ 28.68
epitalon epithalon best injectable dose subcutaneous daily therapeutic benefits Peptide: Anti-Aging Epithalon: The Peptide Linked to
Description
Ara-290 is investigational and not approved by the FDA or any regulator it has been evaluated through Phase 2 trials only and is presented for research and educational use only
Gastrointestinal Cytoprotection Originally studied in gastric lesion models, BPC-157 showed protective effects on: Gastric mucosa Intestinal healing Ulcer repair Reference: Sikiric et al., 1993 Gastric mucosal protection PubMed: Experimentally Observed Benefits of BPC 157 Peptides Below are benefits observed in controlled experimental models
doi: 10.3390/pharmaceutics12121214
We found no selectivity towards senescent IMR90 (Fig
